The heavily scrutinized 340B Drug Pricing Program is back in the spotlight as the Trump administration targets drug costs in a recent Executive Order. The 340B Drug Pricing Program has received a lot ...
Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-Louisiana) recently released the results of an investigation into the 340B Drug Pricing Program. Here are four key ...
The pilot is a significant departure from the current model, which gives hospitals upfront discounts for some drugs. The program has proved a flash point between drugmakers and providers, as ...
Previous reporting has found that many of the organizations bankrolled by PhRMA push messaging critical of pharmacy benefit ...
Key Takeaways - CMS launches Drug Acquisition Cost Survey beginning Jan. 1, 2026. OPPS hospitals must submit NDC-level pricing data for ...
Hospital groups warn the 340B rebate pilot would force safety net providers to front tens of millions of dollars for drugs ...
The federal 340B Drug Pricing Program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to healthcare organizations that care for ...
The American Hospital Association, a Maine hospital group and four nonprofit systems are seeking a temporary restraining ...
Under the 340B program, eligible hospitals buy drugs at a discounted price in order to offset the cost of treating low income ...
The 340B ACCESS Act ensures savings go where they belong: to patients and communities.Protect Delaware’s most vulnerable.
When the 340B drug pricing program was established in 1992, Congress intended for the program to help low-income and uninsured patients with their prescription drugs. The pharmaceutical companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback